SelectScience InterviewsGeneral Lab

Freezing technology behind conjugate vaccine development

23 Jun 2020
Freezing technology behind conjugate vaccine development

‘Everybody in the lab loves a new freezer – it’s cool’. Dr. Andrew Lees, founder, CEO and Scientific Director of Fina Biosolutions, explains how the installation of energy-efficient, reliable, and quickly recovering PHCbi freezers has been vital in enabling the delivery of Fina Biosolutions’s bioconjugation, protein and conjugate vaccine services. He's a magician, who decided to get into the world of science...

About the company

SelectScience logo

SelectScience

Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.

Other videos from SelectScience

Links

Freezing technology behind conjugate vaccine development